Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Docebo (DCBO) EBITDA (2019 - 2025)

Historic EBITDA for Docebo (DCBO) over the last 7 years, with Q3 2025 value amounting to $6.0 million.

  • Docebo's EBITDA rose 520.98% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 193.68%. This contributed to the annual value of $23.4 million for FY2024, which is 26205.72% up from last year.
  • According to the latest figures from Q3 2025, Docebo's EBITDA is $6.0 million, which was up 520.98% from $4.2 million recorded in Q2 2025.
  • Docebo's EBITDA's 5-year high stood at $9.2 million during Q4 2024, with a 5-year trough of -$1.6 million in Q4 2021.
  • In the last 5 years, Docebo's EBITDA had a median value of $3.7 million in 2022 and averaged $3.2 million.
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 43523.21% in 2021, then soared by 201070.11% in 2024.
  • Docebo's EBITDA (Quarter) stood at -$1.6 million in 2021, then skyrocketed by 260.42% to $2.5 million in 2022, then surged by 145.39% to $6.3 million in 2023, then surged by 46.51% to $9.2 million in 2024, then plummeted by 34.33% to $6.0 million in 2025.
  • Its last three reported values are $6.0 million in Q3 2025, $4.2 million for Q2 2025, and $1.5 million during Q1 2025.